Cargando…

Toxic Epidermal Necrolysis: A Case Report on a Drug-Induced Phenomenon

Toxic epidermal necrolysis (TEN) is a group of severe forms of several life-threatening conditions. As a co-infection of this group, Stevens-Johnson syndrome (SJS) is a rare though severe disease of the skin and mucous membranes. Intake of some drugs could cause reactions such as SJS and TEN. A form...

Descripción completa

Detalles Bibliográficos
Autores principales: Pamnani, Soumya, Bakshi, Sanket S, Acharya, Sourya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9671269/
https://www.ncbi.nlm.nih.gov/pubmed/36407163
http://dx.doi.org/10.7759/cureus.30407
_version_ 1784832505739739136
author Pamnani, Soumya
Bakshi, Sanket S
Acharya, Sourya
author_facet Pamnani, Soumya
Bakshi, Sanket S
Acharya, Sourya
author_sort Pamnani, Soumya
collection PubMed
description Toxic epidermal necrolysis (TEN) is a group of severe forms of several life-threatening conditions. As a co-infection of this group, Stevens-Johnson syndrome (SJS) is a rare though severe disease of the skin and mucous membranes. Intake of some drugs could cause reactions such as SJS and TEN. A form of severe connective tissue disorder, TEN is also known as Lyell's syndrome and is a common cause of significant skin and mucous membrane disintegration. Adverse medication reactions are the most prevalent and contribute highly to the incidence rates of the major etiological variables for TEN. Erythema, epidermal detachment that manifests as blisters, and denuded skin patches are the defining features of this pathology. In the majority of cases, the administration of pharmaceutical drugs is thought to be the primary cause of SJS/TEN. In this article, we report a case of a 33-year-old male patient who presented with complaints of lower left facial pain and thus was prescribed carbamazepine. Following this, the patient presented with an adverse reaction to the administration of carbamazepine and was taken off the drug immediately. The treatment included the administration of hydration therapy and appropriate antibiotics for treating the fluid-filled vesicles. The treatment regimen continued for three weeks and was stopped when the skin lesions were scarce and there was an improvement in the overall health of the patient. 
format Online
Article
Text
id pubmed-9671269
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-96712692022-11-18 Toxic Epidermal Necrolysis: A Case Report on a Drug-Induced Phenomenon Pamnani, Soumya Bakshi, Sanket S Acharya, Sourya Cureus Internal Medicine Toxic epidermal necrolysis (TEN) is a group of severe forms of several life-threatening conditions. As a co-infection of this group, Stevens-Johnson syndrome (SJS) is a rare though severe disease of the skin and mucous membranes. Intake of some drugs could cause reactions such as SJS and TEN. A form of severe connective tissue disorder, TEN is also known as Lyell's syndrome and is a common cause of significant skin and mucous membrane disintegration. Adverse medication reactions are the most prevalent and contribute highly to the incidence rates of the major etiological variables for TEN. Erythema, epidermal detachment that manifests as blisters, and denuded skin patches are the defining features of this pathology. In the majority of cases, the administration of pharmaceutical drugs is thought to be the primary cause of SJS/TEN. In this article, we report a case of a 33-year-old male patient who presented with complaints of lower left facial pain and thus was prescribed carbamazepine. Following this, the patient presented with an adverse reaction to the administration of carbamazepine and was taken off the drug immediately. The treatment included the administration of hydration therapy and appropriate antibiotics for treating the fluid-filled vesicles. The treatment regimen continued for three weeks and was stopped when the skin lesions were scarce and there was an improvement in the overall health of the patient.  Cureus 2022-10-17 /pmc/articles/PMC9671269/ /pubmed/36407163 http://dx.doi.org/10.7759/cureus.30407 Text en Copyright © 2022, Pamnani et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Internal Medicine
Pamnani, Soumya
Bakshi, Sanket S
Acharya, Sourya
Toxic Epidermal Necrolysis: A Case Report on a Drug-Induced Phenomenon
title Toxic Epidermal Necrolysis: A Case Report on a Drug-Induced Phenomenon
title_full Toxic Epidermal Necrolysis: A Case Report on a Drug-Induced Phenomenon
title_fullStr Toxic Epidermal Necrolysis: A Case Report on a Drug-Induced Phenomenon
title_full_unstemmed Toxic Epidermal Necrolysis: A Case Report on a Drug-Induced Phenomenon
title_short Toxic Epidermal Necrolysis: A Case Report on a Drug-Induced Phenomenon
title_sort toxic epidermal necrolysis: a case report on a drug-induced phenomenon
topic Internal Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9671269/
https://www.ncbi.nlm.nih.gov/pubmed/36407163
http://dx.doi.org/10.7759/cureus.30407
work_keys_str_mv AT pamnanisoumya toxicepidermalnecrolysisacasereportonadruginducedphenomenon
AT bakshisankets toxicepidermalnecrolysisacasereportonadruginducedphenomenon
AT acharyasourya toxicepidermalnecrolysisacasereportonadruginducedphenomenon